Transcription of ANNUAL REPORT 2017 - viforpharma.com
{{id}} {{{paragraph}}}
Example: marketing
ANNUAL REPORT 2017 - viforpharma.com
ANNUAL . REPORT . 2017 . ANNUAL REPORT 2017 . AT A GLANCE. Guidance raised at half-year, continued good performance in H2. led to strong full-year results Net sales CHF 1, million, up on a constant currency basis EBITDA CHF million, up excluding Veltassa launch costs Cash net of debt of CHF million Transformation into a pure-play pharmaceutical company successfully completed Separation of Galenica Sant via initial public offering (IPO). Etienne Jornod re-elected as Executive Chairman with remuneration exclusively in shares blocked until 2020.
Vifor Pharma Ltd. Annual Report 2017 3 172 02 2017 at a glance 03 Table of contents 04 Ee ivexcut maegsse 08 Highlighs t 10 Our vision, mission and strategy 14 Perorf manceoeervwi v ...
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: